Barclays Raises Johnson & Johnson (JNJ) Price Target After Updated Estimates
Affected assets and topics
Why it matters
Barclays raised Johnson & Johnson's price target to $197 from $176 and refreshed its estimates, maintaining an Equal Weight rating.
Article tone
Expected market reaction
Market impact analysis based on bullish sentiment with 75% confidence.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 17994
Original source
Johnson & Johnson (NYSE:JNJ) is included among the 15 Dividend Stocks that Outperform the S&P 500. Barclays lifted its price target on Johnson & Johnson (NYSE:JNJ) to $197 from $176 on December 2 while maintaining an Equal Weight rating. The firm also refreshed its estimates for the company. Johnson & Johnson (NYSE:JNJ) continues to benefit […]
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on December 3, 2025. Analysis and insights provided by AnalystMarkets AI.